Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Synergy between rapamycin and FLT3 ligand enhances plasmacytoid dendritic cell–dependent induction of CD4 + CD25 + FoxP3 + Treg

Moanaro Biswas, Debalina Sarkar, Sandeep R. P. Kumar, Sushrusha Nayak, Geoffrey L. Rogers, David M. Markusic, Gongxian Liao, Cox Terhorst, Roland W. Herzog

Blood (2015) 125 (19): 2937–2947.

https://doi.org/10.1182/blood-2014-09-599266

Published: 2015

Includes: Supplemental data

Journal Articles

Strategies to Prevent or Reverse Immune Responses Against Factor In Gene Replacement for Hemophilia B.

Sushrusha Nayak, PhD, Babak Moghimi, MD, Roland W Herzog, PhD

Blood (2010) 116 (21): 3761.

https://doi.org/10.1182/blood.V116.21.3761.3761

Published: 2010

Journal Articles

Humoral and Anaphylactic Responses to Factor IX In Murine Hemophilia B Are Genotype Dependent and Can Be Reversed by Hepatic Gene Transfer

David Markusic, PhD, Sushrusha Nayak, PhD, Roland W Herzog, PhD

Blood (2010) 116 (21): 2202.

https://doi.org/10.1182/blood.V116.21.2202.2202

Published: 2010

Journal Articles

A Prophylactic Protocol for the Prevention of Inhibitor Formation in Gene Therapy for Hemophilia B by Shifting the Balance from An Effector to a Regulatory T Cell Response

Sushrusha Nayak, MS, Brad Hoffman, PhD, Mario Cooper, BS, Mark Atkinson, PhD, Ou Cao, MD/PhD, Roland W. Herzog, PhD

Blood (2008) 112 (11): 3531.

https://doi.org/10.1182/blood.V112.11.3531.3531

Published: 2008

Journal Articles

Induction and role of regulatory CD4 + CD25 + T cells in tolerance to the transgene product following hepatic in vivo gene transfer

Ou Cao, Eric Dobrzynski, Lixin Wang, Sushrusha Nayak, Bethany Mingle, Cox Terhorst, Roland W. Herzog

Blood (2007) 110 (4): 1132–1140.

https://doi.org/10.1182/blood-2007-02-073304

Published: 2007

Journal Articles

Regulatory CD4+CD25+ T Cells Are Required for Tolerance Induction to Factor IX by In Vivo Gene Transfer.

Ou Cao, MD, PhD, Lixin Wang, PhD, Sushrusha Nayak, BS, Roland W. Herzog, PhD

Blood (2006) 108 (11): 452.

https://doi.org/10.1182/blood.V108.11.452.452

Published: 2006

NARROW

Synergy between rapamycin and FLT3 ligand enhances plasmacytoid dendritic cell–dependent induction of CD4 + CD25 + FoxP3 + Treg

Strategies to Prevent or Reverse Immune Responses Against Factor In Gene Replacement for Hemophilia B.

Humoral and Anaphylactic Responses to Factor IX In Murine Hemophilia B Are Genotype Dependent and Can Be Reversed by Hepatic Gene Transfer

A Prophylactic Protocol for the Prevention of Inhibitor Formation in Gene Therapy for Hemophilia B by Shifting the Balance from An Effector to a Regulatory T Cell Response

Induction and role of regulatory CD4 + CD25 + T cells in tolerance to the transgene product following hepatic in vivo gene transfer

Regulatory CD4+CD25+ T Cells Are Required for Tolerance Induction to Factor IX by In Vivo Gene Transfer.

Email alerts

ASH Publications

American Society of Hematology

Synergy between rapamycin and FLT3 ligand enhances plasmacytoid dendritic cell–dependent induction of CD4 + CD25 + FoxP3 + Treg

Strategies to Prevent or Reverse Immune Responses Against Factor In Gene Replacement for Hemophilia B.

Humoral and Anaphylactic Responses to Factor IX In Murine Hemophilia B Are Genotype Dependent and Can Be Reversed by Hepatic Gene Transfer

A Prophylactic Protocol for the Prevention of Inhibitor Formation in Gene Therapy for Hemophilia B by Shifting the Balance from An Effector to a Regulatory T Cell Response

Induction and role of regulatory CD4 + CD25 + T cells in tolerance to the transgene product following hepatic in vivo gene transfer

Regulatory CD4+CD25+ T Cells Are Required for Tolerance Induction to Factor IX by In Vivo Gene Transfer.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only